Trials / Sponsors / CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Observational Study to Assess the Safety of rhTNK-tPA (Mingfule®) vs. Rt-PA (Actilyse®) in Treating Acute Isch Acute Ischemic Stroke, rhTNK-tPA | — | 2026-04-10 |
| Recruiting | Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window. Acute Ischemic Stroke | Phase 3 | 2025-11-30 |
| Completed | The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEM Acute ST Elevation Myocardial Infarction | Phase 4 | 2016-05-01 |